Literature DB >> 8202141

NF-AT components define a family of transcription factors targeted in T-cell activation.

J P Northrop1, S N Ho, L Chen, D J Thomas, L A Timmerman, G P Nolan, A Admon, G R Crabtree.   

Abstract

The NF-AT transcription complex is required for the expression of a group of proteins that collectively coordinate the immune response. Here we purify two proteins encoded by separate genes that represent the pre-existing (p) and cytosolic (c) components of NF-AT. Expression of the full-length complementary DNA encoding NF-ATc activates the interleukin (IL-2) promoter in non-T lymphocytes, whereas a dominant negative of NF-ATc specifically blocks activation of the IL-2 promoter in T lymphocytes, indicating that NF-ATc is required for IL-2 gene expression. NF-ATc RNA expression is largely restricted to lymphoid tissues and is induced upon T-cell activation. The other protein, NF-ATp, is highly homologous to NF-ATc over a limited domain which shows similarity to the Dorsal/Rel family, but has a wider tissue distribution. Agents that increase intracellular Ca2+ or activate protein kinase C independently modify NF-ATc, indicating that distinct signalling pathways converge on NF-ATc to regulate its function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202141     DOI: 10.1038/369497a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  177 in total

1.  NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun.

Authors:  C Lopez-Rodríguez; J Aramburu; A S Rakeman; A Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  A second calcineurin binding site on the NFAT regulatory domain.

Authors:  S Park; M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Evolutionary relationships among Rel domains indicate functional diversification by recombination.

Authors:  I A Graef; J M Gastier; U Francke; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

4.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.

Authors:  Robert Berland; Henry H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

6.  Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.

Authors:  Maria Alejandra Alfonso-Jaume; Rajeev Mahimkar; David H Lovett
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

Review 7.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

8.  Involvement of hydrogen peroxide in asbestos-induced NFAT activation.

Authors:  Jingxia Li; Bihui Huang; Xianglin Shi; Vincent Castranova; Val Vallyathan; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type.

Authors:  E R Chin; E N Olson; J A Richardson; Q Yang; C Humphries; J M Shelton; H Wu; W Zhu; R Bassel-Duby; R S Williams
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

10.  Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells.

Authors:  K T Shaw; A M Ho; A Raghavan; J Kim; J Jain; J Park; S Sharma; A Rao; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.